Martin Nyaga

Prof. Martin Nyaga

University of the Free State, Bloemfontein, South Africa
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 January 2014 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
MSMapaseka Seheri
Mapaseka Seheri
LNLeah Msc Nemarude
Leah Msc Nemarude
IPIna Msc Peenze
Ina Msc Peenze
LNLufuno Msc Netshifhefhe
Lufuno Msc Netshifhefhe
Martin NyagaMartin Nyaga
Martin Nyaga
JMJeffrey M. Mphahlele
Jeffrey M. Mphahlele
Background: The African Rotavirus Surveillance Network has been detecting and documenting rotavirus genotypes in the subcontinent since 1998, largely based on intercountry workshops conducted at Rotavirus Regional Reference Laboratories. This article reports on rotavirus genotypes generated at Regional Reference Laboratories, South Africa between 2007 and 2011 from 16 African countries. Methods: Stool samples were collected from <5-year-old children with diarrhea following World Health Organization criteria of hospital-based rotavirus surveillance. Enzyme immunoassay (EIA) was performed by National Laboratories. Regional Reference Laboratories retested 10% of randomly selected EIA positives and 10% of EIA negatives from each country as part of quality control. At least 50 rotavirus EIA positives from each country per year were subjected to reverse transcriptase polymerase chain reaction based on G-/P-types. Sequencing was conducted in 5–10% of each representative G or P genotype to confirm the genotype, as well as to type some of the samples that could not be genotyped with reverse transcriptase polymerase chain reaction-based methods. Results: A total of 2555 of rotavirus EIA positives were genotyped. G1 was the most predominant (28.8%), followed by G9 (17.3%), G2 (16.8%), G8 (8.2%), G12 (6.2%) and G3 (5.9%). Similarly, the P[8] strain was the most prevalent (40.6%), followed by P[6] (30.9%) and P[4] (13.9%). The top G/P combinations detected were G1P[8] (18.4%), G9P[8] (11.7%), G2P[4] (8.6%), G2P[6] (6.2%), G1P[6] (4.9%), G3P[6] (4.3%), G8P[6] (3.8%) and G12P[8] (3.1%). Conclusions: There is high genetic diversity of rotavirus strains circulating in the subcontinent. Understanding the strain diversity pre- and postvaccine introduction are important in Africa to understand the broader impact of the rotavirus vaccines on regionally circulating strains.

26 July 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
CCChrispin Chaguza
Chrispin Chaguza
ICInnocent Chibwe
Innocent Chibwe
DCDavid Chaima
David Chaima
PMPatrick Musicha
Patrick Musicha
LNLatif Ndeketa
Latif Ndeketa
Khuzwayo Chidiwa JereKhuzwayo Chidiwa Jere
Khuzwayo Chidiwa Jere
Malawi experienced its deadliest Vibrio cholerae (Vc) outbreak following devastating cyclones, with >58,000 cases and >1700 deaths reported between March 2022 and May 2023. Here, we use population genomics to investigate the attributes and origin of the Malawi 2022–2023 Vc outbreak isolates. Our results demonstrate the predominance of ST69 clone, also known as the seventh cholera pandemic El Tor (7PET) lineage, expressing O1 Ogawa (~ 80%) serotype followed by Inaba (~ 16%) and sporadic non-O1/non-7PET serogroups (~ 4%). Phylogenetic reconstruction revealed that the Malawi outbreak strains correspond to a recent importation from Asia into Africa (sublineage AFR15). These isolates harboured known antimicrobial resistance and virulence elements, notably the ICEGEN/ICEVchHai1/ICEVchind5 SXT/R391-like integrative conjugative elements and a CTXφ prophage with the ctxB7 genotype compared to historical Malawian Vc isolates. These data suggest that the devastating cyclones coupled with the recent importation of 7PET serogroup O1 strains, may explain the magnitude of the 2022–2023 cholera outbreak in Malawi.

1 January 2014 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Open access
NKNicholas Kiulia
Nicholas Kiulia
Martin NyagaMartin Nyaga
Martin Nyaga
MSMapaseka Seheri
Mapaseka Seheri
MWMarianne Wolfaardt
Marianne Wolfaardt
WZWalda B. van Zyl
Walda B. van Zyl
ANAtunga Nyachieo
Atunga Nyachieo
Background: The World Health Organization has recommended that rotavirus (RV) vaccines be included in all national immunization programs as part of a strategy to control RV-associated diarrheal diseases. Hospital-based surveillance of RV infection is therefore crucial in monitoring the impact pre- and post-vaccine introduction and also to document changes in genotype distribution. This study sought to determine the RV genotypes circulating in the eastern region of Kenya before introduction of the RV vaccine. Methods: During September 2009 to August 2011, 500 stool samples were collected from children <5 years of age admitted for acute diarrhea in hospitals in the eastern region of Kenya and analyzed for the presence of group A RV using an enzyme immunoassay. G and P genotypes were determined using hemi-nested reverse transcriptase polymerase chain reaction. Results: One hundred and eighty nine out of 500 (38%) samples analyzed were positive for rotavirus. The following G types were detected: G9 (50.9%), G1 (26.8%), G8 (12.1%), G12 (3.1%), G2 (0.6%), mixed G (1.3%) and 5.1% were G nontypeable. P types detected included: P[8] (63.7%), P[4] (12.1%), P[6] (4.5%), mixed P (7.6%) and 12.1% were P nontypeable. The most dominant strain was G9P[8] (35%), followed by G1P[8] (26.8%), G8P[4] (9.6%), G12P[6] (2.5%), G9P[6] (1.9%), G9P[4] (1.3%), G8P[8] (1.3%), and G2P[4] (0.6%). Conclusions: The present study demonstrates the recurring changing genotypes of RV circulating in Kenya, with genotypes G9, G1 and G8 being the dominant strains circulating in the eastern region of Kenya between 2009 and 2011. Additionally, G12 genotype was detected for the first time in Kenya.

20 May 2014 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
NMNonkululeko B. Magagula
Nonkululeko B. Magagula
MEMathew D. Esona
Mathew D. Esona
Martin NyagaMartin Nyaga
Martin Nyaga
KSKarla M. Stucker
Karla M. Stucker
RHRebecca A. Halpin
Rebecca A. Halpin
MMM. Jeffrey Mphahlele
M. Jeffrey Mphahlele

1 January 2014 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
Khuzwayo Chidiwa JereKhuzwayo Chidiwa Jere
Khuzwayo Chidiwa Jere
MEMathew D. Esona
Mathew D. Esona
YAYahia H. Ali
Yahia H. Ali
IPIna Peenze
Ina Peenze
SRSunando Roy
Sunando Roy
MSMapaseka Seheri
Mapaseka Seheri